Pharmacological interventions for the treatment of aortic root and heart valve disease-Reference-Cited by-同舟云学术

Pharmacological interventions for the treatment of aortic root and heart valve disease

Published:2021-12-13 Issue:12 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Morselli Franca¹²,McNally Ryan³,Nesti Lorenzo⁴,Liu Boyang⁵,Khan Haris⁶,Thomson Ross J⁷,Stevenson Alex⁸,Banerjee Amitava⁹,Ahmad Mahmood¹⁰,Hanif Moghees⁷,Steeds Richard⁵,Khan Mansoor¹¹

Affiliation:

1. School of Cardiovascular Medicine and Sciences; King's College London; London UK

2. Department of Cardiology; East Kent Hospitals Univestity NHS Foundation Trust; Kent UK

3. Department of Clinical Pharmacology; King's College London; London UK

4. Department of Clinical and Experimental Medicine; University of Pisa; Pisa Italy

5. Department of Cardiology; University Hospitals Birmingham (Queen Elizabeth) NHS Foundation Trust; Birmingham UK

6. Department of Renal Medicine; Guys and St Thomas NHS Foundation Trust; London UK

7. William Harvey Research Institute; Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London UK

8. Department of Acute Medicine; Royal Free NHS Foundation Trust; London UK

9. Institute of Health Informatics Research; University College London; London UK

10. Department of Cardiology; Royal Free Hospital, Royal Free London NHS Foundation Trust; London UK

11. School of Medicine; Keele University; Keele UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference95 articles.

1. Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol;Journal of Bone and Mineral Research,2000

2. Classes of heart failure www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure

3. Is the use of renin-angiotensin systeminhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis;Andersson;European Heart Journal - Cardiovascular Pharmacotherapy,2017

4. Left ventricular dysfunction: causes, natural history, and hopes for reversal;Armstrong;Heart,2000